News coverage of Neoplas Med and Argon Jetplasma

“An innovation from Greifswald gives hope to patients with chronic wounds – and revolutionizes medical technology.”

This is how several German media outlets are currently summarizing the significance of our argon jet plasma therapy. Under the headline “Closing wounds with cold plasma,” the Berliner Morgenpost, the Hamburger Abendblatt, and the Westdeutsche Allgemeine Zeitung, among others, reported in detail on our groundbreaking innovation.

The focus is on our innovative technology and its effectiveness. Neoplas Med Managing Director Ulrike Sailer and Klaus Ruhnau, responsible for clinical research and product development, also explain the potential of argon cold plasma and the areas of application that will open up in the future.

What has particularly motivated me is the fact that numerous patients have contacted us since the publication.”, said Ulrike Sailer. “This demonstrates what we at Neoplas Med are working towards: translating innovations into meaningful patient outcomes.”

The response in the media encourages us in our daily work. It shows that medical progress begins where it creates real help, hope, and new perspectives for people.